Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

GlobeNewswireNov 27 05:00

Does Acumen Pharmaceuticals (NASDAQ:ABOS) Have A Healthy Balance Sheet?

Simply Wall StNov 16 20:45

BofA Securities Maintains Acumen Pharmaceuticals(ABOS.US) With Buy Rating

Futu NewsNov 13 23:33 · Ratings

Express News | Acumen Pharmaceuticals Inc : BofA Global Research Cuts Price Objective to $12 From $14

BreakingsNov 13 23:14

H.C. Wainwright Maintains Acumen Pharmaceuticals(ABOS.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 13 20:31 · Ratings

Acumen Pharmaceuticals Advances Alzheimer's Therapeutic

TipRanksNov 13 12:37